What quality looks like in making offers for population-based screening is an important question given that screening brings potential harms as well as possible benefits. This blog post is about a discussion involving experts to probe that very question — and what it revealed.
Natalie is Professor of Healthcare Improvement Research in the Department of Health Sciences, University of Leicester. She currently holds a Health Foundation Improvement Science Fellowship, which she is using to explore issues of overdiagnosis and overtreatment and how these can be tackled at the health system level. She is a member of the UK National Screening Committee’s Adult Reference Group and its Ethics Task Force.
Related content and links
The PHE Screening team
Public Health England (PHE) existed to protect and improve the nation’s health and wellbeing, and reduce health inequalities. It closed on 30 September 2021 and this blog is no longer updated.
Find out more about the implications for health screening in our Changes ahead for the national screening system blog article.
If you want to stay in touch with screening evidence and policy news, you can subscribe to the UK National Screening Committee blog.
Comments and moderation
- Changes ahead for the national screening system 30 September 2021
- What we blogged about in August and September 2021 30 September 2021
- New resources to help improve quality of samples taken in NHS newborn blood spot screening 30 September 2021